Chemolieve is the L-Nutra’s second Fasting Mimicking Diet program. Chemolieve is a 4-day FMD currently undergoing clinical testing at five different hospitals to evaluate whether it supports the body during chemotherapy, and it could help with decreasing side effects and recovery. Chemolieve® clinical trials are being conducted at the University of Southern California, Mayo Clinic, Leiden University, and the University of Genoa.
Chemolieve® is the first 4-day meal replacement based on proprietary dietary interventions to supply the body with important nutrients to reduce adverse side effects of chemotherapy and enhancing the expiry of unregulated cancer cells.
According to literature data, patients undergoing prolonged periods of fasting prior to, during and after chemotherapy, have reported reduction in a wide range of side effects. The most important critical issue is that fasting for patients with malignancies would be very risky and difficult to follow and since one or more cycles of fasting and chemotherapy may lead to additional malnourishment.
Chemolieve is based on discoveries made at leading US research universities including the finding that specific formulated diets, low in sugars and proteins, may increase tumor cell death in various type of cancer mostly breast cancer, melanoma, glioma, neuroblastoma.